StonvexLoading…
StonvexStonvexStonvexCore line items from GL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $5.99B | $5.78B | $5.45B | $1.38B |
Operating Income | $1.44B | $1.33B | $1.27B | $318.81M |
Net Income | $1.16B | $1.07B | $970.75M | $257.08M |
EPS (Diluted) | $14.07 | $11.94 | $10.07 | $2.68 |
Total Assets | $30.81B | $29.08B | $28.05B | $26.22B |
Total Liabilities | $24.84B | $23.77B | $23.56B | $21.60B |
Cash & Equivalents | $144.70M | $165.32M | $103.16M | Not available |
Free Cash Flow OCF − CapEx | $1.25B | $1.33B | $1.43B | Not available |
Shares Outstanding | 92.22M | 97.22M | 102.22M | Not available |